{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:49:22Z","timestamp":1793260162824,"version":"4.5.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Interest is emerging regarding the role of blood biomarkers in acute stroke. The aim of this pilot study was to determine the feasibility of biomarker acquisition in suspected acute stroke, using modern ultrasensitive immunoassay techniques, and explore their potential usefulness for stroke diagnosis and management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In 62 patients with suspected acute stroke, blood samples were prospectively obtained upon arrival and prior to neuroimaging. Serum levels of glial fibrillary acidic protein (sGFAP) and neurofilament light chain (sNfL) were analyzed using a single molecule array (SIMOA\n                      <jats:sup>\u00ae<\/jats:sup>\n                      ) method, according to time of symptom onset, neuroimaging, and final diagnosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Acute ischemic stroke (AIS) was diagnosed in 35 patients, 10 with large-vessel occlusion (LVO). The remaining were diagnosed with intracerebral hemorrhage (ICH) (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f12), transient ischemic attack (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f4), and stroke mimics (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f11). Median (IQR) sGFAP levels were significantly higher in ICH (2,877.8 [1,002.1\u201310,402.5] pg.\/mL) compared to others diagnoses. In AIS, GFAP levels appear to increase with longer delays since symptom onset and were higher in patients with more extensive ischemic changes on baseline CT (ASPECTS \u22647) than those without, particularly in LVO stroke. NfL values were similar across groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In acute stroke, serum GFAP levels show potential as an adjunct tool for the distinction between ICH and AIS. Specific to AIS, GFAP may also offer insight into time from onset, and extent of ischemic tissue injury on neuroimaging, particularly in LVO stroke. These preliminary findings merit further study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2024.1470718","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T11:14:37Z","timestamp":1733483677000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Serum glial fibrillary acidic protein in acute stroke: feasibility to determine stroke-type, timeline and tissue-impact"],"prefix":"10.3389","volume":"15","author":[{"given":"Julien F.","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lina","family":"Ducroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Daigneault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Larochelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Stapf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Gioia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1212\/WNL.0b013e318219fb30","article-title":"Population-based study of wake-up strokes","volume":"76","author":"Mackey","year":"2011","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00117-018-0406-4","article-title":"DAWN and DEFUSE-3 trials: is time still important?","volume":"58","author":"Ragoschke-Schumm","year":"2018","journal-title":"Radiologie"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1177\/1747493018806167","article-title":"Glial fibrillary acidic protein for the early diagnosis of intracerebral hemorrhage: systematic review and meta-analysis of diagnostic test accuracy","volume":"14","author":"Perry","year":"2019","journal-title":"Int J Stroke"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/j.1468-1331.2006.01435.x","article-title":"Release of glial fibrillary acidic protein is related to the neurovascular status in acute ischemic stroke","volume":"13","author":"Wunderlich","year":"2006","journal-title":"Eur J Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1007\/s00415-019-09477-9","article-title":"Circulating neurofilament light in ischemic stroke: temporal profile and outcome prediction","volume":"266","author":"Pedersen","year":"2019","journal-title":"J Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1373\/clinchem.2016.263335","article-title":"Glial fibrillary acidic protein serum levels distinguish between intracerebral hemorrhage and cerebral ischemia in the early P hase of stroke","volume":"63","author":"Luger","year":"2017","journal-title":"Clin Chem"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13049-022-01065-7","article-title":"Diagnostic performance of glial fibrillary acidic protein and prehospital stroke scale for identification of stroke and stroke subtypes in an unselected patient cohort with symptom onset\u202f<\u202f4.5 h","volume":"31","author":"J\u00e6ger","year":"2023","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1021\/acssensors.1c02232","article-title":"Detection of glial fibrillary acidic protein in patient plasma using on-Chip graphene field-effect biosensors, in comparison with ELISA and Single-molecule Array","volume":"7","author":"Xu","year":"2022","journal-title":"ACS Sens"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1354750X.2019.1691657","article-title":"Role of glial fibrillary acidic protein as a biomarker in differentiating intracerebral haemorrhage from ischaemic stroke and stroke mimics: a meta-analysis","volume":"25","author":"Kumar","year":"2020","journal-title":"Biomarkers"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/clinchem\/hvab128","article-title":"Ultra-early differential diagnosis of acute cerebral ischemia and hemorrhagic stroke by measuring the prehospital release rate of GFAP","volume":"67","author":"Mattila","year":"2021","journal-title":"Clin Chem"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1212\/WNL.0000000000002860","article-title":"Early CT changes in patients admitted for thrombectomy","volume":"87","author":"Farzin","year":"2016","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1089\/neu.2020.7140","article-title":"Point-of-care platform blood biomarker testing of glial fibrillary acidic protein versus S100 calcium-binding protein B for prediction of traumatic brain injuries: a transforming research and clinical knowledge in traumatic brain injury study","volume":"37","author":"Okonkwo","year":"2020","journal-title":"J Neurotrauma"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000537998","article-title":"Advances in prehospital Management of Intracerebral Hemorrhage","author":"Gioia","year":"2024","journal-title":"Cerebrovasc Dis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1056\/NEJMoa2314741","article-title":"Intensive ambulance-delivered blood-pressure reduction in Hyperacute stroke","volume":"390","author":"Li","year":"2024","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13054-024-04892-5","article-title":"GFAP point-of-care measurement for prehospital diagnosis of intracranial hemorrhage in acute coma","volume":"28","author":"Zylyftari","year":"2024","journal-title":"Crit Care"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e1928","DOI":"10.1212\/WNL.0000000000011742","article-title":"Blood biomarkers to differentiate ischemic and hemorrhagic strokes","volume":"96","author":"Bustamante","year":"2021","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e001304","DOI":"10.1161\/SVIN.123.001304","article-title":"Prospective validation of glial fibrillary acidic protein, D-dimer, and clinical scales for acute large vessel occlusion ischemic stroke detection","volume":"4","author":"Durrani","year":"2024","journal-title":"Stroke"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1177\/23969873211010069","article-title":"Serum GFAP for stroke diagnosis in regions with limited access to brain imaging (BE FAST India)","volume":"6","author":"Kalra","year":"2021","journal-title":"Eur Stroke J"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"24588","DOI":"10.1038\/srep24588","article-title":"Assessment of serum UCH-L1 and GFAP in acute stroke patients","volume":"6","author":"Ren","year":"2016","journal-title":"Sci Rep"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1515\/cclm-2015-1195","article-title":"Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa","volume":"54","author":"Kuhle","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1177\/0271678X231172520","article-title":"Quantification and prospective evaluation of serum NfL and GFAP as blood-derived biomarkers of outcome in acute ischemic stroke patients","volume":"43","author":"Ferrari","year":"2023","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e62101","DOI":"10.1371\/journal.pone.0062101","article-title":"Blood levels of glial fibrillary acidic protein (GFAP) in patients with neurological diseases","volume":"8","author":"Mayer","year":"2013","journal-title":"PLoS One"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1470718\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T04:37:11Z","timestamp":1735015031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1470718\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":23,"alternative-id":["10.3389\/fneur.2024.1470718"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1470718","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,6]]},"article-number":"1470718"}}